TY - JOUR
T1 - Neuroimaging Markers of Resiliency in Youth at Clinical High Risk for Psychosis
T2 - A Qualitative Review
AU - Vargas, Teresa
AU - Damme, Katherine S.F.
AU - Ered, Arielle
AU - Capizzi, Riley
AU - Frosch, Isabelle
AU - Ellman, Lauren M.
AU - Mittal, Vijay A.
N1 - Funding Information:
This work was supported by National Institute of Mental Health Grant Nos. F31MH119776 [to TV], F31MH119720 [to AE], R01MH112613 [to LME], R01MH118545 [to LME], R01MH120091 [to LME], 1R01MH112545 [to VAM], R01120088 [to VAM], R01MH116039 [to VAM], MH119677 [to VAM], and MH110374 [to VAM].
Publisher Copyright:
© 2020 Society of Biological Psychiatry
PY - 2021/2
Y1 - 2021/2
N2 - Psychotic disorders are highly debilitating and constitute a major public health burden. Identifying markers of psychosis risk and resilience is a necessary step toward understanding etiology and informing prevention and treatment efforts in individuals at clinical high risk (CHR) for psychosis. In this context, it is important to consider that neural risk markers have been particularly useful in identifying mechanistic determinants along with predicting clinical outcomes. Notably, despite a growing body of supportive literature and the promise of recent findings identifying potential neural markers, the current work on CHR resilience markers has received little attention. The present review provides a brief overview of brain-based risk markers with a focus on predicting symptom course. Next, the review turns to protective markers, examining research from nonpsychiatric and schizophrenia fields to build an understanding of framing, priorities, and potential, applying these ideas to contextualizing a small but informative body of resiliency-relevant CHR research. Four domains (neurocognition, emotion regulation, allostatic load, and sensory and sensorimotor function) were identified and are discussed in terms of behavioral and neural markers. Taken together, the literature suggests significant predictive value for brain-based markers for individuals at CHR for psychosis, and the limited but compelling resiliency work highlights the critical importance of expanding this promising area of inquiry.
AB - Psychotic disorders are highly debilitating and constitute a major public health burden. Identifying markers of psychosis risk and resilience is a necessary step toward understanding etiology and informing prevention and treatment efforts in individuals at clinical high risk (CHR) for psychosis. In this context, it is important to consider that neural risk markers have been particularly useful in identifying mechanistic determinants along with predicting clinical outcomes. Notably, despite a growing body of supportive literature and the promise of recent findings identifying potential neural markers, the current work on CHR resilience markers has received little attention. The present review provides a brief overview of brain-based risk markers with a focus on predicting symptom course. Next, the review turns to protective markers, examining research from nonpsychiatric and schizophrenia fields to build an understanding of framing, priorities, and potential, applying these ideas to contextualizing a small but informative body of resiliency-relevant CHR research. Four domains (neurocognition, emotion regulation, allostatic load, and sensory and sensorimotor function) were identified and are discussed in terms of behavioral and neural markers. Taken together, the literature suggests significant predictive value for brain-based markers for individuals at CHR for psychosis, and the limited but compelling resiliency work highlights the critical importance of expanding this promising area of inquiry.
KW - Biomarker
KW - Clinical high risk for psychosis
KW - Magnetic resonance imaging
KW - Neuroimaging
KW - Resilience
KW - Schizophrenia
UR - http://www.scopus.com/inward/record.url?scp=85089296999&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089296999&partnerID=8YFLogxK
U2 - 10.1016/j.bpsc.2020.06.002
DO - 10.1016/j.bpsc.2020.06.002
M3 - Review article
C2 - 32788085
AN - SCOPUS:85089296999
SN - 2451-9022
VL - 6
SP - 166
EP - 177
JO - Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
JF - Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
IS - 2
ER -